Please review product information before prescribing.
Full prescribing information upon request from oppi-ra@otsuka.com.ph
For medical information queries, please email: oppi-medicalinfo@otsuka.com.ph.
For product related concerns, please email: oppi-pqc@otsuka.com.ph

For suspected adverse drug reaction, please report to the Food and Drug Administration (FDA) at www.fda.gov.ph and to the Otsuka (Philippines) Pharmaceutical, Inc. Local Safety Unit via email at oppi-pv@otsuka.com.ph; via phone:+ 63 999 886 9910, +632 8844 9266 or +632 8888 6774 and via fax: +632 8811 2279.

At the first sign of any adverse drug reaction, the patient should seek medical attention immediately.